| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 江中药业股份有限公司是一家属江西省医药行业类的公司.公司主营中成药、中药制剂、抗生素原料药、抗生素制剂等.公司以生产OTC类药品为主,主导产品有江中复方草珊瑚含片、江中健胃消食片、江中亮嗓等,市场竞争力极强,江中亮嗓更荣膺"中国药品市场消费者喜爱的品牌"。 公司“高标准康复营养活性肽产品开发关键技术与产业化”获江西省科技进步二等奖；“一种增强人体免疫功能的保健食品及其制备工艺”获江西省专利奖；新增发明专利授权20件，实用新型专利授权14件，新增注册商标129件；2022年度“科改示范企业”考核获评“优秀”。 公司围绕“智慧江中”定位，把握数字经济发展机遇，聚焦“智能制造、治理智能化应用、数字化营销、网络安全及信创、技术平台化及数据要素化”等五个方面，将数字化转型由制造向公司治理、营销、网络安全等领域拓展，全面开展智数赋能。公司EHSQ系统、海斯制药ERP系统上线，多个营销数字化应用落地，多套数字系统升级，提升生产经营效率，保障网络安全，持续打造智能与数字化标杆基层单位。 | ||||||||||||||||||||||||
| Main Business | 从事药品和大健康产品的生产、研发与销售。 | ||||||||||||||||||||||||
| Legal Representative | 刘为权 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 田永静 | ||||||||||||||||||||||||
| Solicitors | 国浩律师集团（上海）事务所 | ||||||||||||||||||||||||
| Auditors | 中磊会计师事务所有限责任公司 | ||||||||||||||||||||||||
| Tel No | 0791-88169323 | ||||||||||||||||||||||||
| Fax No | 0791-88164004 | ||||||||||||||||||||||||
| Website | www.jzjt.com | ||||||||||||||||||||||||
| jzyy@crjz.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 23/09/1996 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 1.120 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 1.300 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 6.087 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 13.666B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |